Mono Pharmacare Limited (NSE:MONOPHARMA)
India
· Delayed Price · Currency is INR 25.00
+1.00 (4.17%)
At close: May 16, 2025
Mono Pharmacare Revenue
Mono Pharmacare had revenue of 872.06M INR in the half year ending September 30, 2024, with 270.87% growth. This brings the company's revenue in the last twelve months to 1.43B, up 87.77% year-over-year. In the fiscal year ending March 31, 2024, Mono Pharmacare had annual revenue of 1.22B with 269.41% growth.
Revenue (ttm)
1.43B
Revenue Growth
+87.77%
P/S Ratio
0.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
441.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.22B | 892.92M | 269.41% |
| Mar 31, 2023 | 331.44M | -39.50M | -10.65% |
| Mar 31, 2022 | 370.93M | 87.15M | 30.71% |
| Mar 31, 2021 | 283.78M | 166.91M | 142.81% |
| Mar 31, 2020 | 116.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |